The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging
2025 · Nature Medicine · 53 citations
https://doi.org/10.1038/s41591-025-03834-0
R
Rowan Saloner
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
1.3K
Citations
19
h-index
37
i10-index
Rowan Saloner is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Dementia and Cognitive Impairment Research & HIV Research and Treatment & HIV-related health complications and treatments. The author has an h-index of 19, co-authored 101 publications.
ORCID: 0000-0002-1351-6183Papers by this author
worksThe association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV
2022 · Journal of NeuroVirology · 10 citations
https://doi.org/10.1007/s13365-022-01076-1
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
2024 · Research Square · 8 citations
https://doi.org/10.21203/rs.3.rs-4103685/v1
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder
2022 · Journal of NeuroVirology · 4 citations
https://doi.org/10.1007/s13365-021-01046-z
Data-driven physical actigraphy patterns relate to cognitive and vascular health in older adults
2023 · Experimental Gerontology · 3 citations
https://doi.org/10.1016/j.exger.2023.112231
Opposing role of phagocytic receptors MERTK and AXL in Progranulin deficient FTD
2025 · Communications Biology · 1 citations
https://doi.org/10.1038/s42003-025-08368-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat